The genomic sequence of a rotavirus group H was identified in the intestine of a diarrheal pig in the United States, designated RVH/Pig-wt/USA/MN9.65/2008/GxP[x].
R otaviruses (RVs), which are members of the family Reoviridae, are a common cause of viral gastroenteritis in humans and in the young of various vertebrates (1) . Rotavirus possesses an RNA genome composed of 11 double-stranded segments, encoding six structural (VPs) and five nonstructural proteins (NSPs) (1) . The genome is assigned the complete descriptor of Gx-P[x]-Ix-Rx-CxMx-Ax-Nx-Tx-Ex-Hx for VP7, VP4, VP6, VP1 to VP3, and NSP1-5/6, respectively, with x indicating the numbers of corresponding genotypes (2) . RVs are classified into eight antigenically defined groups, rotavirus A to H (RVA to RVH) (3). RVA strains are well known for their high prevalence and pathogenesis in humans and animals, possessing either Wa-like genogroup 1 constellation (G1-P[1]-I1-R1-C1-M1-A1-N1-T1-E1-H1) or Ds-1-like genogroup 2 constellation (G2-P[2]-I2-R2-C1-M2-A2-N2-T2-E2-H2). RVB, RVC, and RVH are also known to infect humans and a limited number of animals. RVD, RVE, RVF, and RVG have been detected only in birds or pigs (2, 4) . In 1997, a rotavirus strain infecting humans, adult diarrhea rotavirus (ADRV-N) (5, 6), was identified, which did not belong to previously established groups; however, it was later identified as RVH, based on VP6 sequence analysis (3). Subsequently, RVH has been detected in humans, as strain J19 in China (7), strain B219 in Bangladesh (5, 8) , and in pigs from Japan (9), Brazil (10), and South Africa (11) .
Here, we report the first genomic sequence for all 11 segments of a porcine RVH strain from the United States. On 16 April 2008, the University of Minnesota Veterinary Diagnostic Laboratory received three intestinal samples from 4-week-old pigs with clinical signs of diarrhea, coughing, and failure to thrive. These samples from Minnesota were homogenized together, as previously described (12) , and determined to be positive for RVA, RVB, RVC, and RVH by reverse transcription-PCR (RT-PCR) (13, 14) .
We used a previously described viral metagenomics approach to enrich and sequence viral nucleic acids, followed by MiSeq and de novo assembly of the resulting reads (15) . Briefly, viral RNA was reversely transcribed and amplified using a random primer. A next-generation sequencing (NGS) library was prepared, using the Nextera XT kit; sequencing followed using Illumina's MiSeq platform. A total of 766,560 reads were generated, de novo assembled, and analyzed in the bioinformatics pipeline, as described previously (16) .
We obtained the following near-complete sequences for RVH strain MN9.65: for VP1 (segment 1, 3,369 bp); VP2 (segment 2, 2,977 bp); VP3 (segment 3, 1,167 bp); VP4 (segment 4, 1,275 bp); NSP1 (segment 5, 1,248 bp), the only segment containing the entire coding region; NSP3 (segment 7, 408 bp); NSP2 (segment 8, 913 bp); VP7 (segment 9, 456 bp); NSP4 (segment 10, 687 bp); and NSP5/6 (segment 11, 493 bp). The VP6 gene was deposited previously (14) . This RVH strain MN9.65 shares 88% (VP1), 90% (VP2), 90% (VP3), 88% (VP4), 82% (VP7), 88% (NSP1), 90% (NSP2), 94% (NSP3), and 85% (NSP4) nucleotide identity with porcine RVH strain SKA-1 from Japan. Obtaining all 11 segments of RVH will facilitate further rotavirus H surveillance in pigs globally and allow for the development of improved screening methods for RVH strains.
Nucleotide sequence accession numbers. The sequences for RHV/MN9.65/2008 have been deposited in GenBank under accession numbers KU254582 to KU254592.
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